Showing results (241-250 of 295) with videos related to

Sort By:
Pageof 30
Journal of Gastroenterology|February 23, 2017
Validation of serological models for staging and prognostication of HCC in patients from a Japanese nationwide surveyHienori Toyoda, Toshifumi Tada, Philip J Johnson, et al.
British Journal of Cancer|February 22, 2023
'Potentially curative therapies' for hepatocellular carcinoma: how many patients can actually be cured?Alessandro Cucchetti, Omar Elshaarawy, Guohong Han, et al.
Journal of Viral Hepatitis|September 26, 2020
Impact of direct-acting antiviral agents on liver function in patients with chronic hepatitis C virus infectionPhilip J Johnson, Sarah Berhane, Alex J Walker, et al.
Respiration; International Review of Thoracic Diseases|October 27, 2022
Crossover Patient Outcomes for Targeted Lung Denervation in Moderate to Severe Chronic Obstructive Pulmonary Disease: AIRFLOW-2Francesca Conway, James Tonkin, Arschang Valipour, et al.
Iscience|March 10, 2025
Development and evaluation of an international teleproctoring program for bronchoscopic proceduresFrancesca M Conway, Anand Tana, Cielito Caneja, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 29, 2013
Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic massStephen L Chan, Frankie Mo, Philip J Johnson, et al.
Journal of the National Cancer Institute|November 7, 2002
Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinomaAnthony T C Chan, Y M Dennis Lo, Benny Zee, et al.
American Journal of Clinical Oncology|August 3, 2005
Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudineWinnie Yeo, Edwin P Hui, Anthony T C Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapyStephen L Chan, Frankie K F Mo, Philip J Johnson, et al.
Pageof 30